[1]谌登珍,马 强.血清补体C1q、C3与中性粒细胞胞浆抗体相关性血管炎患者临床特征、病理类型及预后相关性研究[J].陕西医学杂志,2023,52(1):105-109.[doi:DOI:10.3969/j.issn.1000-7377.2023.01.025]
　CHEN Dengzhen,MA Qiang.Correlation between serum complement C1q,C3 and clinical features,pathological types and prognosis of patients with ANCN-associated vasculitis[J].,2023,52(1):105-109.[doi:DOI:10.3969/j.issn.1000-7377.2023.01.025]
点击复制

血清补体C1q、C3与中性粒细胞胞浆抗体相关性血管炎患者临床特征、病理类型及预后相关性研究
分享到：

《陕西医学杂志》[ISSN:1000-7377/CN:61-1281/TN]

卷:
52
期数:
2023年1期
页码:
105-109
栏目:
临床病理
出版日期:
2023-01-05

文章信息/Info

Title:
Correlation between serum complement C1q,C3 and clinical features,pathological types and prognosis of patients with ANCN-associated vasculitis
作者:
谌登珍1; 马 强2
(1.商洛市中心医院呼吸内科,陕西 商洛 726000; 2.商洛市中心医院呼吸与危重症医学科,陕西 商洛 726000)
Author(s):
CHEN Dengzhen; MA Qiang
(Department of Respiratory Medicine,Shangluo Central Hospital,Shangluo 726000,China)
关键词:
补体C1q;  补体C3;  中性粒细胞胞浆抗体相关性血管炎;  临床特征;  病理类型;  预后
Keywords:
Complement C1q;  Complement C3;  ANCN-associated vasculitis;  Clinical features;  Pathological types;  Prognosis
分类号:
R 543
DOI:
DOI:10.3969/j.issn.1000-7377.2023.01.025
文献标志码:
A
摘要:
目的:分析抗中性粒细胞胞浆抗体(ANCA)相关性血管炎患者临床症状、病理类型、血清补体C1q、C3及临床预后等状况,探究血清补体C1q、C3在ANCN相关性血管炎患者中的临床价值。方法:选取88例ANCA相关性血管炎(AAV)患者作为观察组研究对象,同期选取进行体检的88例健康患者作为对照组研究对象。根据血清补体C1q水平将AAV患者分为低C1q组与正常C1q组; 根据血清补体C3水平将AAV患者分为低C3组与正常C3组。①比较观察组与对照组患者血清补体C1q、C3水平; ②对不同C1q水平组别患者基本资料及实验室指标进行比较; ③分析血清补体C1q水平与患者临床特征、病理类型及预后的关系; ④对不同C3水平组别患者基本资料及实验室指标进行比较; ⑤分析血清补体C3水平与患者临床特征、病理类型及预后的关系。结果:①与对照组相比,观察组的AAV患者体内血清补体C1q、C3水平明显降低(均P>0.05)。②低 C1q 组和正常C1q组患者性别、年龄、ANCA分型以及C3水平比较均无统计学差异(均P>0.05),低 C1q 组β2-微球蛋白(β-2MG)水平显著高于正常C1q组,免疫球蛋白M(IgM)、红细胞计数(RBC)、血红蛋白(Hb)以及乳酸脱氢酶(LDH)水平显著低于正常C1q组(均P<0.05)。③低 C1q 组和正常C1q组患者各项临床特征的发生率以及病理类型比较均无统计学差异(均P>0.05),低 C1q 组终末期肾脏病(ESRD)的发生率明显高于正常C1q组(P<0.05)。④低 C3 组和正常C3组患者性别、年龄、ANCA分型以及C1q水平比较均无统计学差异(均P>0.05),低 C3组β-2MG、血尿素氮(BUN)、胱抑素C(CysC)、腱生蛋白(Tn)、脑钠肽(BNP)以及LDH水平显著高于正常C3组,PLT、WBC、以及Hb水平显著低于正常C3组(均P<0.05)。⑤低 C3 组和正常C3组患者各项临床特征的发生率以及病理类型比较均无统计学差异(均P>0.05),低 C3 组ESRD的发生率明显高于正常C3组(P<0.05)。结论:AAV患者体内血清补体 C1q、C3 水平明显低于健康人群,低 C1q、C3水平的AAV患者临床预后明显更差,同时发现低C3水平AAV患者肾功能受损严重,在临床实践中要密切注意患者血清补体 C1q、C3 水平,早期对患者采取积极有效的措施进行干预,改善预后,具有很高的临床诊疗价值。
Abstract:
Objective:To analyze the clinical symptoms,pathological types,serum complement C1q,C3 and clinical outcomes of patients with neutrophil cytoplasmic antibody(ANCA)-associated vasculitis,and to explore the clinical value of serum complement C1q and C3 in ANCN-associated vasculitis.Methods:A total of 88 patients with ANCA-associated vasculitis(AAV)were selected as the observation group,and 88 healthy patients who underwent physical examination during the same period were selected as the control group.AAV patients were divided into low C1q group and normal C1q group according to serum complement C1q level,and divided into low C3 group and normal C3 group according to serum complement C3 level.The serum complement C1q and C3 levels in the observation group and the control group were recorded and compared.The basic data and laboratory indexes of patients in different C1q level groups were compared,and the relationship between serum complement C1q level and clinical characteristics,pathological types and prognosis of patients was analyzed.The basic data and laboratory indexes of patients in different C3 level groups were compared,and the relationship between serum complement C3 level and clinical characteristics,pathological types and prognosis of patients was analyzed.Results:Compared with the control group,the serum levels of complement C1q and C3 in the observation group were significantly decreased(all P<0.05).There was no significant difference in sex,age,ANCA classification and C3 levels between the low-C1q and normal-C1q groups(all P>0.05).The level of β-2MG in lower-C1q group was higher than that in normal-C1q group,while the levels of IgM,RBC,Hb and LDH were lower than those in normal-C1q group(all P<0.05).No significant difference was found between the low- and normal-C1q groups in the incidence of all clinical characteristics and pathological types(all P>0.05),and the low-C1q group had a significantly higher incidence of ESRD than the normal-C1q group(all P<0.05).There was no significant difference in sex,age,ANCA classification and C1q level between the low-and normal-C3 groups(all P>0.05),while the levels of β-2MG,BUN,CysC,Tn,BNP and LDH in low-C3 group were higher than those in normal-C3 group,and the levels of PLT,WBC and Hb were lower than those in normal-C3 group(all P<0.05).There was no significant difference in the incidence of clinical characteristics and pathological types between the low-C3 group and the normal-C3 group(all P>0.05),while the incidence of ESRD in the low-C3 group was significantly higher than that in the normal-C3 group(all P<0.05).Conclusion:The serum levels of complement C1q and C3 in AAV patients are significantly lower than those in healthy people,and the clinical prognosis of AAV patients with low C1q and C3 levels is significantly worse.In clinical practice,it is necessary to pay close attention to the serum complement C1q and C3 levels of patients,and to take active and effective measures to intervene in patients in the early stage to improve the prognosis,which has a high clinical diagnosis and treatment value.

参考文献/References:

[1] 王 鑫,刘维萍.抗中性粒细胞胞浆抗体相关性血管炎治疗研究进展[J].中华肾病研究电子杂志,2022,11(1):33-38.
[2] 蒋 婷,张 倩,殷小伟,等.1例抗中性粒细胞胞浆抗体相关性血管炎的临床表现[J].实用临床医药杂志,2021,25(15):79-81.
[3] 常 洁,刘俊英,郭志玲.中性粒细胞与淋巴细胞比值与抗中性粒细胞胞浆抗体相关性小血管炎预后的相关研究[J].甘肃医药,2018,37(10):914-916.
[4] 胡 剑,高春林,张 沛,等.抗中性粒细胞胞质抗体相关性血管炎发病机制及治疗的研究进展[J].中华肾脏病杂志,2020,36(5):412-416.
[5] 王淑平,刘树军,李起奉,等.抗中性粒细胞胞浆抗体相关性血管炎肾损伤临床及病理研究[J].中国实验诊断学,2021,25(9):1335-1337.
[6] 谢家琪,武英虎,彭 博,等.抗中性粒细胞胞质抗体相关性血管炎合并间质性肺疾病的临床特征与预后[J].河南医学研究,2021,30(14):2504-2507.
[7] 蒋艳君,李 永,唐 彬.ANCA相关性小血管炎的病理分型特点及预后影响因素[J].当代医学,2022,28(3):154-156.
[8] 刘 姣,方茹梦,王 涛,等.抗中性粒细胞胞质抗体相关性血管炎合并感染的临床特点及预后分析[J].中华全科医学,2021,19(9):1480-1483.
[9] 高 锐,高 珺,孙 玲,等.参芪地黄汤加减治疗肾病综合征疗效及对患者血清免疫球蛋白和补体的影响[J].陕西中医,2022,43(8):1060-1063.
[10] 王 军,欧 理,周清梓,等.直肠癌患者术后血清补体C3、C4水平变化及其与术后疼痛的相关性研究[J].陕西医学杂志,2019,48(8):984-986,996.
[11] 苏丽雅?艾山江.ANCA相关性血管炎伴补体C3水平降低患者的预后及相关危险因素分析[D].乌鲁木齐:新疆医科大学,2019.
[12] 张金玉,曹玉涵,叶寅寅,等.补体在ANCA相关性血管炎中作用的研究进展[J].大连医科大学学报,2021,43(4):354-358.
[13] 陈文洁.高血压脑出血患者血清补体C3、C4与免疫球蛋白水平检测的临床意义[J].湖北民族大学学报:医学版,2021,38(4):83-85.
[14] 董 莉.血清补体C3、C4以及抗C1q抗体水平与系统性红斑狼疮患者病情的相关性[J].河南医学研究,2020,29(34):6386-6388.
[15] 包 娇,程一春,邵菊芳,等.抗中性粒细胞胞质抗体相关性血管炎患者治疗后继发感染的危险因素[J].中华肾脏病杂志,2019,35(5):351-358.
[16] 严 华,余志杰.中性粒细胞与淋巴细胞比值联合补体C1q在急性冠脉综合征患者主要心血管不良事件预测中的价值[J].临床医学研究与实践,2021,6(14):104-106.
[17] 朱龙英,胡启擂,周国丽.补体C1q、C3、C4及B因子联合检测对妊娠相关血栓性微血管病的早期诊断价值[J].中国妇幼保健,2021,36(23):5418-5421.
[18] 焦文妤,尚家璐,李树霞.慢性阻塞性肺疾病患者血清补体C1q肿瘤坏死因子相关蛋白5与肺功能及炎症反应相关性研究[J].陕西医学杂志,2019,48(12):1616-1618,1621.
[19] 许 丹,果基牛牛,汪亚丽.高龄卒中患者血清补体C1q、C3及C4水平动态变化对心血管事件预后评估作用及影响因素分析[J].公共卫生与预防医学,2022,33(1):141-145.
[20] 宋 林.血清补体C3和C4检测对自身免疫性肝炎患者病情评估的价值[J].中国医药指南,2022,20(1):131-133.
[21] 陈益家,唐佳佳,刘世举.八珍散加减改善结直肠癌根治术后患者胃肠功能和免疫功能临床研究[J].陕西中医,2021,42(5):577-581.
[22] 宋向荣,屈 姗,张 茜,等.血管炎的临床特点及预后分析[J].临床医药文献电子杂志,2018,5(42):13-15,17.
[23] 李 想,张 倩,聂春迎,等.伴补体C3降低的ANCA相关性小血管炎1例并文献复习[J].中国中西医结合肾病杂志,2019,20(5):450-451,374.
[24] 谢丽娇,张 瑞,贺江花,等.ANCA相关性血管炎伴血清补体C3降低的临床分析[J].免疫学杂志,2017,33(5):410-414,421.
[25] 宋 娜.补体C1q、C3在ANCA相关性血管炎中的临床意义及相关性分析[D].长春:吉林大学,2021.

相似文献/References:

[1]赵雪千,王雯瑾,张楠辉,等.IgA肾病患者补体血清水平及其系膜沉积强度与肾病理损伤程度的相关性[J].陕西医学杂志,2025,54(4):555.[doi:DOI:10.3969/j.issn.1000-7377.2025.04.024]

备注/Memo

备注/Memo:
基金项目:陕西省重点研发计划项目(2017SF-059)
更新日期/Last Update: 2022-12-28